Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa

ObjectiveTo evaluate the efficacy of ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) against bloodstream infections (BSIs) or lower respiratory tract infections (LRTIs) – caused by extensive drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa.MethodThe two-fold dilution m...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yixin Kang, Lu Xie, Jiyong Yang, Junchang Cui
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-06-01
Col·lecció:	Frontiers in Cellular and Infection Microbiology
Matèries:	extensively drug-resistant Pseudomonas aeruginosa pan drug-resistant Pseudomonas aeruginosa ceftazidime-avibactam 173 aztreonam-avibactam whole-genome sequencing
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fcimb.2023.1023948/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!